Cutting-Edge Cardiac Research: Novoheart’s CTScreen™ system has been installed at UMC Utrecht, equipping Regenerative Medicine Center with advanced high-throughput tools to accelerate human cardiac ...

The Harvard Pilgrim Health Care Institute is proud to announce the launch of the Center for Sepsis Epidemiology and ...

Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) ...

"This research provides crucial insights into how the immune system functions in sickle cell disease," said Dr. Karina Yazdanbakhsh, Vice President and Director of Research at New York Blood Center ...

Background Cardiovascular disease (CVD) remains a significant public health challenge in China. This study aimed to project ...

Nearly three-quarters of U.S. adults (72%) say the COVID-19 pandemic did more to drive the country apart than to bring it together. Fresh data delivered Saturday mornings Overall, a slim majority of ...

Players aren’t the only ones under pressure as the game clock ticks down. By Harvey Araton A Times writer was browsing the gray columns of newsprint when a photograph transported him to the ...

Over the past decade, the research enterprise at the University of Nevada, Reno has grown substantially thanks to our commitment to building an inclusive, diverse and collaborative research ...

Bristol Heart Institute is a world-leading centre for translational cardiovascular research and the leading academic cardiac surgery centre in the UK. We specialise in preventing, predicting, ...

2025 — Research has established a clear link between racial and ethnic disparities in maternal heart health and higher risks of preterm birth, preeclampsia and cardiovascular issues for Black ...

Nearly three-quarters of U.S. adults (72%) say the COVID-19 pandemic did more to drive the country apart than to bring it together. Fresh data delivered Saturday mornings Nearly three-quarters of U.S.

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.